Sol-Gel Technologies (SLGL) Return on Capital Employed Growth (1y) (2019 - 2026)
Sol-Gel Technologies (SLGL) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,805.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 19,453.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -3,457.00 |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | 19.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.00 |
| Dec 31, 2025 | 3,651.00 |
| Sep 30, 2025 | 1,984.00 |
| Jun 30, 2025 | 5,682.00 |
| Mar 31, 2025 | 4,486.00 |
| Dec 31, 2024 | 2,080.00 |
| Sep 30, 2024 | 2,247.00 |
| Jun 30, 2024 | 196.00 |
| Mar 31, 2024 | -3,471.00 |
| Dec 31, 2023 | -918.00 |
| Sep 30, 2023 | -4,976.00 |
| Jun 30, 2023 | -5,279.00 |
| Mar 31, 2023 | -4,617.00 |
| Dec 31, 2022 | -6,324.00 |
| Sep 30, 2022 | 1,604.00 |
| Jun 30, 2022 | 4,849.00 |
| Mar 31, 2022 | 5,711.00 |
| Dec 31, 2021 | 5,695.00 |
| Sep 30, 2021 | 7,865.00 |
| Jun 30, 2021 | 2,572.00 |